Emergent Biosolutions reported $82.1M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Akebia Therapeutics AKBA:US $ 46.36M 4.71M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Amarin AMRN:US 102.96M 4.24M
Ani Pharmaceuticals ANIP:US $ 17.18M 1.64M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Chimerix CMRX:US 4.89M 479K
Coherus Biosciences CHRS:US $ 39.92M 420K
Emergent Biosolutions EBS:US $ 82.1M 9.1M
Exact Sciences EXAS:US $ 383.16M 20.7M
Exelixis EXEL:US $ 101.56M 3.06M
Flexion Therapeutics FLXN:US $ 26.99M 423K
Glaxosmithkline GSK:US 2.5B 6M
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Immunogen IMGN:US $ 10.3M 569K
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Ironwood Pharmaceuticals IRWD:US $ 27.74M 690K
JAZZ PHA JAZZ:US 363.68M 65.35M
Lexicon Pharmaceuticals LXRX:US 7.3M 633K
Merk MRK:US $ 2.27B 9M
Moderna Inc MRNA:US 168M 47M
Myriad Genetics MYGN:US $ 180.2M 45.4M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Opko Health OPK:US $ 105.12M 8.12M
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Pfizer PFE:US $ 2.73B 61M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Teva Pharmaceutical Industries TEVA:US 864M 32M
United Therapeutics UTHR:US $ 109.1M 3.7M
Vanda Pharmaceuticals VNDA:US $ 32.46M 4.11M
Xoma XOMA:US $ 4.26M 328K